We are live on ! Find out more
Schroder Investment Management Group

Schroder Investment Management Group Portfolio holdings

AUM $141B
1-Year Est. Return 34.18%
This Fund
S&P 500
This Quarter Est. Return
+20.7%
1 Year Est. Return
+34.18%
3 Year Est. Return
+121.7%
5 Year Est. Return
+159.58%
10 Year Est. Return
+614.8%
AUM
$141B
AUM Growth
+$19.1B
Cap. Flow
+$768M
Cap. Flow %
0.54%
Top 10 Hldgs %
33.33%
Holding
1,287
New
111
Increased
516
Reduced
480
Closed
120

Sector Composition

Rank Sector Weight
1 Technology 32.86%
2 Financials 12.22%
3 Communication Services 10.97%
4 Consumer Discretionary 9.78%
5 Industrials 8.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FWONA icon
1126
Liberty Media Corporation Series A Common Stock
FWONA
$21.7B
$43.8K ﹤0.01%
500
-5,838
-92% -$480K
ZD icon
1127
Ziff Davis
ZD
$1.94B
$27.5K ﹤0.01%
527
– –
UPST icon
1128
Upstart Holdings
UPST
$2.32B
$26.5K ﹤0.01%
756
– –
ABUS icon
1129
Arbutus Biopharma
ABUS
$961M
– –
-121,313
Closed -$522K
ABVX
1130
Abivax
ABVX
$7.95B
– –
-17,928
Closed -$1.82M
AFG icon
1131
American Financial Group
AFG
$11.5B
– –
-1,776
Closed -$227K
AKAM icon
1132
Akamai
AKAM
$16.4B
– –
-46,057
Closed -$5.29M
ALKS icon
1133
Alkermes
ALKS
$6.85B
– –
-67,458
Closed -$2.03M
ALT icon
1134
Altimmune
ALT
$595M
– –
-667,837
Closed -$1.92M
APAM icon
1135
Artisan Partners
APAM
$2.57B
– –
-47,655
Closed -$1.7M
ARWR icon
1136
Arrowhead Research
ARWR
$9.31B
– –
-162,005
Closed -$9.34M
EFOR
1137
Everforth Inc
EFOR
$1.36B
– –
-887,692
Closed -$33.9M
ASND icon
1138
Ascendis Pharma A/S
ASND
$14.8B
– –
-67,902
Closed -$14.8M
AVT icon
1139
Avnet
AVT
$8.46B
– –
-43,430
Closed -$2.54M
AXSM icon
1140
Axsome Therapeutics
AXSM
$10.2B
– –
-23,830
Closed -$3.82M
BILI icon
1141
Bilibili
BILI
$6.13B
– –
-486,141
Closed -$10.5M
BMRN icon
1142
BioMarin Pharmaceuticals
BMRN
$11.7B
– –
-56,334
Closed -$3.18M
BRC icon
1143
Brady Corp
BRC
$3.94B
– –
-3,895
Closed -$313K
CCL icon
1144
Carnival Corporation Ltd
CCL
$30.5B
– –
-145,759
Closed -$3.77M
CGEM icon
1145
Cullinan Oncology
CGEM
$953M
– –
-173,740
Closed -$2.33M
CMPS
1146
Compass Pathways
CMPS
$1.81B
– –
-300,000
Closed -$1.57M
CPB icon
1147
Campbell Soup
CPB
$5.78B
– –
-25,817
Closed -$573K
CSTL icon
1148
Castle Biosciences
CSTL
$1.09B
– –
-298,941
Closed -$7.04M
CTRA
1149
DELISTED
Coterra Energy
CTRA
– –
-10,210,977
Closed -$359M
DD icon
1150
DuPont de Nemours
DD
$17.8B
– –
-464,910
Closed -$61.7M

Similar funds

Schroder Investment Management Group's Q2 2026 Portfolio in Review

As of Q2 2026, Schroder Investment Management Group held 1,287 positions worth $141B, up 16% from $122B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Schroder Investment Management Group's Q2 2026 filing shows 111 new, 516 increased, 480 reduced and 120 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 2,250,640 shares worth $217M. The largest sale was Arm, an estimated $519M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 30% a quarter earlier, followed by Financials and Communication Services.

  • Schroder Investment Management Group's largest Q2 2026 buy was iShares Core MSCI EAFE ETF: 2,250,640 shares worth $217M.
  • Schroder Investment Management Group added most to UnitedHealth in Q2 2026, an estimated $714M increase.
  • Schroder Investment Management Group's biggest Q2 2026 reduction was Arm, cutting an estimated $519M.
  • Schroder Investment Management Group fully exited Coterra Energy in Q2 2026, selling an estimated $359M.
  • Schroder Investment Management Group's ten largest holdings make up 33% of its $141B portfolio in Q2 2026.
  • Schroder Investment Management Group opened 111 new positions and closed 120 in Q2 2026.
  • Schroder Investment Management Group's portfolio value rose 16% quarter-over-quarter to $141B.

Based on Schroder Investment Management Group's 13F filing for Q2 2026, filed 13 Aug 2026.